An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer
Producción científica: Artículo Científico › Artículo original › revisión exhaustiva
1Cita
(Scopus)
Huella
Profundice en los temas de investigación de 'An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer'. En conjunto forman una huella única.